Edition:
United Kingdom

Apellis Pharmaceuticals Inc (APLS.OQ)

APLS.OQ on NASDAQ Stock Exchange Global Select Market

18.69USD
14 Dec 2018
Change (% chg)

$-0.02 (-0.11%)
Prev Close
$18.71
Open
$18.62
Day's High
$18.96
Day's Low
$18.33
Volume
120,111
Avg. Vol
102,892
52-wk High
$31.69
52-wk Low
$11.45

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.640
Jun '18 0.00 -0.609
Mar '18 0.00 -0.432
FY 2017 Dec '17 0.00 -0.371
Sep '17 0.00 -0.235
Jun '17 0.00 -0.246
Mar '17 0.00 -0.184
FY 2016 Dec '16 0.00 -0.134
Sep '16 0.00 -0.146
Jun '16
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 3 0.00 0.00 0.00 --
Quarter Ending Mar-19 2 0.00 0.00 0.00 --
Year Ending Dec-18 3 0.00 0.00 0.00 0.00
Year Ending Dec-19 3 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Dec-18 4 -0.70 -0.65 -0.75 -0.38
Quarter Ending Mar-19 4 -0.73 -0.70 -0.77 --
Year Ending Dec-18 4 -2.41 -2.35 -2.45 -1.36
Year Ending Dec-19 4 -3.04 -2.85 -3.24 -1.70
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.13 34.39
P/E High - Last 5 Yrs. -- 40.59 46.24
P/E Low - Last 5 Yrs. -- 23.99 24.59
Beta -- 0.91 0.91
Price to Sales (TTM) -- 4.00 6.22
Price to Book (MRQ) -- 5.02 5.20
Price to Tangible Book (MRQ) -- 5.76 6.74
Price to Cash Flow (TTM) -- 23.20 24.17
% Owned Institutions -- 0.95 1.78

Dividends

  Company industry sector
Dividend Yield -- 1.55 1.44
Dividend Yield - 5 Year Avg -- 1.56 1.46
Dividend 5 Year Growth Rate -- 4.21 4.94
Payout Ratio(TTM) -- 45.68 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 2.33 8.17
Sales (TTM) vs TTM 1 Yr. Ago -- 4.80 6.50
Sales - 5 Yr. Growth Rate -- 10.00 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 17.26 23.09
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 9.88 10.49
Capital Spending - 5 Yr. Growth Rate -- 15.23 14.59

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.20 2.28
Current Ratio (MRQ) -- 3.02 3.10
LT Debt to Equity (MRQ) -- 8.89 11.49
Total Debt to Equity (MRQ) -- 12.69 16.03
Interest Coverage (TTM) -- 35.18 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.41 54.44
Gross Margin - 5 Yr. Avg. -- 51.86 52.36
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.41 13.16
Operating Margin (TTM) -- 14.42 6.07
Operating Margin - 5 Yr. Avg. -- 14.55 8.47
Pre-Tax Margin (TTM) -- 14.96 7.02
Pre-Tax Margin - 5 Yr. Avg. -- 14.97 8.71
Net Profit Margin (TTM) -- 11.16 3.12
Net Profit Margin - 5 Yr. Avg. -- 11.23 4.91
Effective Tax Rate (TTM) -- 23.45 23.26
Effective Tax Rate - 5 Yr. Avg. -- 23.65 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 997,011,333 873,051,409
Net Income/Employee (TTM) -- 118,232,370 103,483,755
Receivable Turnover (TTM) -- 5.82 5.80
Inventory Turnover (TTM) -- 2.68 3.56
Asset Turnover (TTM) -- 0.99 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.98 11.45
Return on Assets - 5 Yr. Avg. -- 13.28 12.50
Return on Investment (TTM) -- 15.55 14.96
Return on Investment - 5 Yr. Avg. -- 17.28 16.23
Return on Equity (TTM) -- 16.92 16.52
Return on Equity - 5 Yr. Avg. -- 18.21 17.37

Performance for Apellis Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -- -- -- 20
13 Week -- -- -- 34
26 Week -- -- -- 28
52 Week -- -- -- 12
YTD -- -- -- 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 57.62%
# of Holders: 123
Total Shares Held: 32,404,681
3 Mo. Net Change: -883,582
# New Positions: 16
# Closed Positions: 8
# Increased Positions: 62
# Reduced Positions: 41
# Net Buyers: 21
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.